Dr. Jade Anderson, M.D.
What this data tells you about Dr. Anderson
Dr. Jade Anderson is a medical oncology in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Anderson performed 105,132 Medicare services across 3,268 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anderson received a total of $534 from 10 pharmaceutical and/or device companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anderson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 34,680 | $0 | $6 |
| Oxaliplatin chemotherapy injection | 13,800 | $0 | $36 |
| Anti-nausea injection (aprepitant) | 11,570 | $1 | $9 |
| Nivolumab injection (Opdivo) | 8,600 | $24 | $76 |
| Darbepoetin injection (Aranesp) for anemia | 7,790 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 5,200 | $43 | $136 |
| Denosumab injection (Prolia/Xgeva) | 3,360 | $18 | $58 |
| Dexamethasone injection (steroid) | 3,100 | $0 | $1 |
| Injection, atropine sulfate, 0.01 mg | 2,000 | $0 | $2 |
| Injection, granisetron hydrochloride, 100 mcg | 1,500 | $0 | $25 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,450 | $22 | $194 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,260 | $1 | $122 |
| Complete blood count (CBC) with differential | 1,063 | $8 | $35 |
| Injection, leucovorin calcium, per 50 mg | 848 | $3 | $27 |
| Injection of additional new drug or substance into vein | 744 | $12 | $105 |
| Comprehensive metabolic blood panel | 719 | $10 | $62 |
| Blood draw (venipuncture) | 584 | $8 | $19 |
| Injection, irinotecan, 20 mg | 571 | $2 | $211 |
| Injection, fluorouracil, 500 mg | 562 | $2 | $14 |
| Immunoglobulin level test | 402 | $9 | $54 |
| Office visit, established patient (30-39 min) | 401 | $91 | $417 |
| Administration of chemotherapy into vein, 1 hour or less | 369 | $103 | $685 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 359 | $3 | $401 |
| Red blood count automated, with additional calculations | 279 | $5 | $25 |
| Drug injection, under skin or into muscle | 251 | $10 | $93 |
| Office visit, established patient, complex (40-54 min) | 245 | $136 | $561 |
| Ferritin level test (iron stores) | 236 | $13 | $58 |
| Iron level test | 215 | $6 | $26 |
| Iron binding capacity test | 215 | $9 | $34 |
| Injection, zoledronic acid, 1 mg | 174 | $7 | $462 |
| Injection, carboplatin, 50 mg | 171 | $2 | $300 |
| Thyroid stimulating hormone (TSH) test | 167 | $16 | $78 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 164 | $50 | $304 |
| Vitamin B-12 level test | 133 | $15 | $74 |
| Lactate dehydrogenase (enzyme) level | 130 | $6 | $30 |
| Injection, diphenhydramine hcl, up to 50 mg | 130 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 124 | $52 | $334 |
| Immunologic analysis technique on serum (immunofixation) | 123 | $22 | $155 |
| Administration of chemotherapy into vein, each additional hour | 122 | $23 | $156 |
| Protein measurement, serum | 120 | $11 | $96 |
| Infusion into a vein for hydration, each additional hour | 97 | $10 | $73 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 89 | $58 | $316 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 80 | $1 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 79 | $16 | $97 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $132 | $3,938 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 63 | $23 | $152 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 62 | $16 | $91 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 57 | $210 | $986 |
| Hospital follow-up visit, moderate complexity | 55 | $61 | $280 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 51 | $1 | $19 |
| New patient office visit (45-59 min) | 46 | $116 | $639 |
| PSA test (prostate cancer screening) | 45 | $18 | $91 |
| Administration of additional new drug or substance into vein using push technique | 40 | $45 | $281 |
| Carcinoembryonic antigen (cea) protein level | 37 | $19 | $96 |
| Folic acid level test | 34 | $14 | $71 |
| Haptoglobin (serum protein) level | 34 | $12 | $64 |
| Infusion, normal saline solution , 1000 cc | 34 | $2 | $19 |
| Unclassified drugs | 33 | $1 | $9 |
| New patient office visit, complex (60-74 min) | 32 | $156 | $802 |
| Free thyroxine (T4) test | 29 | $9 | $63 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 26 | $27 | $141 |
| Infusion into a vein for hydration, 31-60 minutes | 23 | $26 | $249 |
| Initial hospital admission, high complexity | 20 | $135 | $785 |
| Office visit, established patient (20-29 min) | 18 | $58 | $283 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 15 | $16 | $70 |
| Irrigation of implanted venous access drug delivery device | 14 | $16 | $111 |
| Flu vaccine, quadrivalent | 11 | $76 | $157 |
| Flu vaccine administration | 11 | $30 | $56 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Anderson is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Anderson experienced with iron infusion (feraheme)?
Does Dr. Anderson receive payments from pharmaceutical companies?
How do Dr. Anderson's costs compare to other medical oncologys in Amarillo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology